Tarsus Pharmaceuticals (TARS) Other financing activities (2019 - 2024)

Tarsus Pharmaceuticals' Other financing activities history runs 4 years deep, the most recent figure standing at $39000.0 for Q3 2024.

• In Q3 2024, Other financing activities changed N/A year-over-year to $39000.0; the TTM figure through Dec 2025 stood at $39000.0 (changed 0.0% YoY), while the FY2024 annual figure was $3.5 million, changed N/A from the prior year.
• Other financing activities was $39000.0 for Q3 2024 at Tarsus Pharmaceuticals, down from $60000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $2.1 million in Q4 2020 to a low of $1000.0 in Q2 2020.
• Historically, Other financing activities has averaged $471000.0 across 3 years, with a median of $60000.0 in 2022.
• Biggest YoY gain for Other financing activities was 956.0% in 2020; the steepest drop was 956.0% in 2020.
• A 3-year view of Other financing activities shows it stood at $2.1 million in 2020, then tumbled by 97.16% to $60000.0 in 2022, then sank by 35.0% to $39000.0 in 2024.
• The last three Other financing activities figures came in at $39000.0 (Q3 2024), $60000.0 (Q2 2022), and $815000.0 (Q1 2022), per Business Quant data.